#BCMAtargeting

Multiple myeloma drug Blenrep backed for wider NHS use The revitalisation of GSK's Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple myeloma drug more widely.

The revitalisation of #GSK's #Blenrep has continued with the news that the #NHS in #England can use the #BCMAtargeting #multiplemyeloma drug more widely.